Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Ghana
Ghana: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 96.0% in 2024. ▲ Rising
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Ghana, 2012–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
Ghana recorded 96.0% for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in 2024.
That represents a change of down 3.0% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Ghana peaked at 99.0% in 2014 and was at its lowest, 43.0%, in 2012.
Ghana ranks 15th of 146 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 13 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Ghana, year by year
| Year | % | Change |
|---|---|---|
| 2012 | 43.0% | — |
| 2013 | 89.0% | +107.0% |
| 2014 | 99.0% | +11.2% |
| 2015 | 88.0% | -11.1% |
| 2016 | 93.0% | +5.7% |
| 2017 | 99.0% | +6.5% |
| 2018 | 96.0% | -3.0% |
| 2019 | 97.0% | +1.0% |
| 2020 | 95.0% | -2.1% |
| 2021 | 98.0% | +3.2% |
| 2022 | 99.0% | +1.0% |
| 2023 | 96.0% | -3.0% |
| 2024 | 96.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 88.0% | 43.0% | 99.0% | 8 |
| 2020s | 96.8% | 95.0% | 99.0% | 5 |
Countries ranked near Ghana
More health data for Ghana
- Un projection of annual infant deaths, annual growth rate -1.37 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6224 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 986.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,361 deaths (2100)
- Population ages 0-14, female, annual growth rate 0.736 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1749 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.7544 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1794 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Ghana?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Ghana was 96.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Ghana?
- The highest recorded value was 99.0% in 2014.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Ghana?
- The lowest recorded value was 43.0% in 2012.
- How does Ghana rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Ghana ranks 15th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Ghana?
- Over the last ten years it is down 3.0%. The long-run trend across the full record is rising.
- Where does this Ghana data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 13 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.